Atezolizumab vs best supportive care in resected NSCLC

MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC

Working to improve global cancer care access in low middle-income countries

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer

Low-dose nivolumab leads to improved overall survival for head and neck cancer patients

Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Updates from the PROpel and MAGNITUDE studies

Update on the latest in PARP inhibitors for prostate cancer

Isatuximab + Pd in Difficult-to-Treat Patients with RRMM

ASCO Direct Highlights 2022: prostate cancer highlights

ASCO Direct Highlights 2022: lung cancer highlights

Locally and advanced immunotherapy developments and new agents in lung cancer